A detailed history of Birchbrook, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Birchbrook, Inc. holds 1,771 shares of MRK stock, worth $144,070. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,771
Previous 1,971 10.15%
Holding current value
$144,070
Previous $196 Million 18.93%
% of portfolio
0.09%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jun 10, 2025

SELL
$83.01 - $101.02 $16,602 - $20,204
-200 Reduced 10.15%
1,771 $159 Million
Q4 2024

Jun 10, 2025

BUY
$96.31 - $114.76 $15,891 - $18,935
165 Added 9.14%
1,971 $196 Million
Q3 2024

Jun 10, 2025

BUY
$111.15 - $128.97 $7,002 - $8,125
63 Added 3.61%
1,806 $205 Million
Q1 2024

Jun 10, 2025

SELL
$113.24 - $131.95 $4,869 - $5,673
-43 Reduced 2.41%
1,743 $230 Million
Q4 2023

Jun 10, 2025

BUY
$100.18 - $109.02 $178,921 - $194,709
1,786 New
1,786 $195 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $206B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Birchbrook, Inc. Portfolio

Follow Birchbrook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchbrook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Birchbrook, Inc. with notifications on news.